Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim J Collier

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the American College of Cardiology|May 8, 2019
Statistical Appraisal of 6 Recent Clinical Trials in Cardiology: JACC State-of-the-Art ReviewStuart J Pocock, Tim J Collier
Journal of the American College of Cardiology|May 14, 2018
Critical Appraisal of the 2018 ACC Scientific Sessions Late-Breaking Trials From a Statistician's PerspectiveStuart J Pocock, Tim J Collier
Journal of the American College of Cardiology|December 17, 2015
Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
Journal of the American College of Cardiology|December 15, 2015
Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
Journal of the American College of Cardiology|August 20, 2021
Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art ReviewStuart J Pocock, Xavier Rossello, Ruth Owen, et al.
The Annals of Thoracic Surgery|September 21, 2016
ReplyBilal M Ansari, Maurice P Hogan, Tim J Collier, et al.
The Annals of Thoracic Surgery|September 28, 2015
A Randomized Controlled Trial of High-Flow Nasal Oxygen (Optiflow) as Part of an Enhanced Recovery Program After Lung Resection SurgeryBilal M Ansari, Maurice P Hogan, Tim J Collier, et al.
ESC Heart Failure|September 6, 2022
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trialLuca Monzo, João Pedro Ferreira, John G F Cleland, et al.
European Heart Journal|November 20, 2020
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trialJohn G F Cleland, João Pedro Ferreira, Beatrice Mariottoni, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the American College of Cardiology|May 8, 2019
Statistical Appraisal of 6 Recent Clinical Trials in Cardiology: JACC State-of-the-Art ReviewStuart J Pocock, Tim J Collier
Journal of the American College of Cardiology|May 14, 2018
Critical Appraisal of the 2018 ACC Scientific Sessions Late-Breaking Trials From a Statistician's PerspectiveStuart J Pocock, Tim J Collier
Journal of the American College of Cardiology|December 17, 2015
Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
Journal of the American College of Cardiology|December 15, 2015
Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
Journal of the American College of Cardiology|August 20, 2021
Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art ReviewStuart J Pocock, Xavier Rossello, Ruth Owen, et al.
The Annals of Thoracic Surgery|September 21, 2016
ReplyBilal M Ansari, Maurice P Hogan, Tim J Collier, et al.
The Annals of Thoracic Surgery|September 28, 2015
A Randomized Controlled Trial of High-Flow Nasal Oxygen (Optiflow) as Part of an Enhanced Recovery Program After Lung Resection SurgeryBilal M Ansari, Maurice P Hogan, Tim J Collier, et al.
ESC Heart Failure|September 6, 2022
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trialLuca Monzo, João Pedro Ferreira, John G F Cleland, et al.
European Heart Journal|November 20, 2020
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trialJohn G F Cleland, João Pedro Ferreira, Beatrice Mariottoni, et al.
Pageof 1